Avendus Future Leaders Invests Rs 3 Billion in Aragen Life Sciences
ECONOMY & POLICY

Avendus Future Leaders Invests Rs 3 Billion in Aragen Life Sciences

Aragen Life Sciences, a contract research, development, and manufacturing organisation (CRDMO), has received a Rs 3 billion investment from the Avendus Future Leaders Fund (FLF), a private equity fund managed by the Avendus Group, along with SBI Life Insurance. This investment comes out of Avendus’ third fund, which marks the fund’s second investment, the first being its investment in La Renon Healthcare earlier this year. 
Aragen, established in 2001, is primarily focused on developing innovative pharmaceuticals, though in recent years has started to develop digital and AI technologies. It also offers R&D services for manufacturing. 
Ritesh Chandra, Managing Partner, Avendus FLF, said that the investment underscores their belief in the company’s long‑term growth prospects of the CRDMO market in India and specifically Aragen’s ability to capture the market as well as the market for global pharmaceuticals. He remarked that the CRDMO industry is growing at a rate of 16 per cent, and that India will wield a greater share of this market over the coming years. India’s current share of the global market is 8 per cent, and Chandra expects that number to increase to 14 per cent.
With two investments in the healthcare sector under their belt, Avendus is now seeking investment opportunities in the electronics manufacturing and engineering space. 

Aragen Life Sciences, a contract research, development, and manufacturing organisation (CRDMO), has received a Rs 3 billion investment from the Avendus Future Leaders Fund (FLF), a private equity fund managed by the Avendus Group, along with SBI Life Insurance. This investment comes out of Avendus’ third fund, which marks the fund’s second investment, the first being its investment in La Renon Healthcare earlier this year. Aragen, established in 2001, is primarily focused on developing innovative pharmaceuticals, though in recent years has started to develop digital and AI technologies. It also offers R&D services for manufacturing. Ritesh Chandra, Managing Partner, Avendus FLF, said that the investment underscores their belief in the company’s long‑term growth prospects of the CRDMO market in India and specifically Aragen’s ability to capture the market as well as the market for global pharmaceuticals. He remarked that the CRDMO industry is growing at a rate of 16 per cent, and that India will wield a greater share of this market over the coming years. India’s current share of the global market is 8 per cent, and Chandra expects that number to increase to 14 per cent.With two investments in the healthcare sector under their belt, Avendus is now seeking investment opportunities in the electronics manufacturing and engineering space. 

Related Stories

Gold Stories

Next Story
Products

Koemmerling opens Navi Mumbai experience centre

Koemmerling, a brand of the profine Group, has expanded its presence in the Mumbai metropolitan region with the opening of a new experience centre in Navi Mumbai and launched its Allure S46 minimal sliding door system for the Indian market.Located in CBD Belapur, the facility was inaugurated by Peter Mrosik, Owner and CEO, profine Group, along with Farid Khan, Chairman and Managing Director, profine India, and Kamal Bajaj, CEO, profine India.The company said the new centre will showcase its portfolio of uPVC and aluminium window and door systems to architects, developers and homeowners.The ina..

Next Story
Products

India's waterproofing market nears Rs 150 bn milestone

India's waterproofing industry is approaching a market size of Rs 150 billion and is expected to surpass the $2 billion milestone, according to speakers at the 2nd India International Waterproofers Conference & Expo 2026 organised by the Waterproofers Association of India (WAI) in New Delhi.The two-day event brought together more than 20 speakers, 55 international delegates and 53 exhibition booths, with discussions focusing on climate-resilient construction, advanced waterproofing technologies and international collaboration.Inaugurating the event, Durga Shanker Mishra, former Secretary, ..

Next Story
Real Estate

Dilip Buildcon Q1 FY27 Revenue at Rs 23.78 billion

Dilip Buildcon Limited reported consolidated revenue from operations of Rs 2,378 crore in Q1 FY27, along with EBITDA of Rs 429 crore and profit after tax of Rs 128 crore.Consolidated EBITDA margin stood at 18.1%, improving from 17.1% in Q4 FY26. On a standalone basis, revenue from operations was Rs 1,930 crore, EBITDA stood at Rs 199 crore and PAT was Rs 39 crore, with an EBITDA margin of 10.3%.The company’s order book stood at Rs 27,691 crore as of 30 June 2026, compared with Rs 28,830 crore as of 31 March 2026. Roads and highways accounted for 17.1% of the order book, irrigation and water ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement